Director/PDMR Shareholding

Released : 07 Mar 2017 15:18

RNS Number : 7791Y
Dechra Pharmaceuticals PLC
07 March 2017
 

 

 

 

7 March 2017

 

Dechra Pharmaceuticals PLC

(the Company)

Director Shareholding

 

 

The Company announces that on 7 March 2017 Richard Cotton, Chief Financial Officer, was granted the following awards over ordinary shares of 1 pence each in the Company.  Each award will vest, subject to the satisfaction of a performance condition, on the date specified below:

 

Type of award

Number of shares subject to award

Vesting date

Nil cost option

21,033

3 January 2018

Nil cost option

21,033

15 September 2018

 

These are the recruitment awards referred to in the Company's Directors' Remuneration Report for the year ended 30 June 2016.

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Richard Cotton

 

2.

Reason for the notification

a)

Position/status

Director

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Dechra Pharmaceuticals PLC

b)

LEI code

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 1 pence each

 

 

ISIN: GB0009633180

b)

Nature of the transaction

Grant of nil cost options

c)

Price(s) and volumes(s)

Price(s)

Nil cost

Nil cost

Volume(s)

21,033

21,033

d)

Aggregated information

-   Aggregate volume

-   Price

 

 

N/A

e)

Date of the transaction

2017.03.07

f)

Place of the transaction

Outside a trading venue

 

 

 

For further information, please contact:

 

Suzana Cross, Company Secretary           

Telephone number: 01606 814730

 

 

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKODDPBKDANK